Healthcare provider profile · identity verified

Jean Berra Mueller, GNP

Nurse Practitioner · SAINT LOUIS, MO · NPI 1205947173

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	288	115
Lisinopril	Lisinopril	284	110
Omeprazole	Omeprazole	250	89
Amlodipine Besylate	Amlodipine Besylate	247	93
Losartan Potassium	Losartan Potassium	240	83
Levothyroxine Sodium	Levothyroxine Sodium	226	80
Simvastatin	Simvastatin	201	70
Metoprolol Succinate	Metoprolol Succinate	147	52
Gabapentin	Gabapentin	138	53
Pantoprazole Sodium	Pantoprazole Sodium	138	46
Trazodone Hcl	Trazodone Hcl	127	40
Albuterol Sulfate Hfa	Albuterol Sulfate	126	43
Escitalopram Oxalate	Escitalopram Oxalate	126	50
Rosuvastatin Calcium	Rosuvastatin Calcium	126	48
Methylprednisolone	Methylprednisolone	113	95
Meloxicam	Meloxicam	112	34
Hydrochlorothiazide	Hydrochlorothiazide	110	39
Sertraline Hcl	Sertraline Hcl	107	36
Potassium Chloride	Potassium Chloride	100	32
Furosemide	Furosemide	90	38
Tizanidine Hcl	Tizanidine Hcl	87	33
Ozempic	Semaglutide	82	21
Azithromycin	Azithromycin	79	67
Celecoxib	Celecoxib	75	23
Fluticasone Propionate	Fluticasone Propionate	74	33
Metformin Hcl	Metformin Hcl	72	32
Doxycycline Hyclate	Doxycycline Hyclate	70	54
Eliquis	Apixaban	67	19
Montelukast Sodium	Montelukast Sodium	63	21
Metoprolol Tartrate	Metoprolol Tartrate	62	23
Buspirone Hcl	Buspirone Hcl	60	15
Prednisone	Prednisone	60	43
Duloxetine Hcl	Duloxetine Hcl	59	19
Doxazosin Mesylate	Doxazosin Mesylate	56	14
Pravastatin Sodium	Pravastatin Sodium	55	24
Atenolol	Atenolol	54	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	39
Glipizide	Glipizide	46	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	46	15
Cephalexin	Cephalexin	45	36
Ezetimibe	Ezetimibe	45	15
Metformin Hcl Er	Metformin Hcl	43	21
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	43	37
Amoxicillin	Amoxicillin	42	35
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	17
Citalopram Hbr	Citalopram Hydrobromide	41	15
Januvia	Sitagliptin Phosphate	41	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	39	suppressed
Alendronate Sodium	Alendronate Sodium	37	15
Lovastatin	Lovastatin	37	11
Fluoxetine Hcl	Fluoxetine Hcl	36	12
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Mounjaro	Tirzepatide	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	suppressed
Famotidine	Famotidine	33	12
Glimepiride	Glimepiride	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Spironolactone	Spironolactone	32	suppressed
Allopurinol	Allopurinol	31	13
Mirtazapine	Mirtazapine	30	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	29	29
Jardiance	Empagliflozin	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	22
Valacyclovir	Valacyclovir Hcl	27	17
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Fluconazole	Fluconazole	25	15
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	25	12
Dicyclomine Hcl	Dicyclomine Hcl	23	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	21
Carvedilol	Carvedilol	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Felodipine Er	Felodipine	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Nystatin	Nystatin	18	16
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Dilt-Xr	Diltiazem Hcl	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Clotrimazole	Clotrimazole	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	12
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Finasteride	Finasteride	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Baclofen	Baclofen	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error